Evidence map›Paper›PMID 42639220›Full record

ArticleRSC advances2026

Carbon@CeO

Veronika Sarnatskaya, Petro Virych, Yuliia Shlapa, Victor Mikhailenko, Liubov Paziuk, Viktor Melnyk, Kyrylo Saulenko, Pavlo Virych, Joaquin Silvestre-Albero, Anatolii Belous

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Veronika SarnatskayaR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS 45, Vasylkivska St. Kyiv 03022 Ukraine vsnikavera@gmail.com.
Petro VirychR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS 45, Vasylkivska St. Kyiv 03022 Ukraine vsnikavera@gmail.com.
Yuliia ShlapaV. I. Vernadsky Institute of General and Inorganic Chemistry of the NAS of Ukraine 32/34 Palladina Ave Kyiv 03142 Ukraine yuliashlapa@ukr.net.ORCID https://orcid.org/0000-0002-1732-0962
Victor MikhailenkoR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS 45, Vasylkivska St. Kyiv 03022 Ukraine vsnikavera@gmail.com.
Liubov PaziukEducational-scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv 2 Akademika Hlushkova Ave. 03022 Kyiv Ukraine.
Viktor MelnykNational Cancer Institute of the Ministry of Health of Ukraine 33/43, Yulia Zdanovska St. Kyiv 03022 Ukraine.
Kyrylo SaulenkoR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS 45, Vasylkivska St. Kyiv 03022 Ukraine vsnikavera@gmail.com.ORCID https://orcid.org/0000-0003-0938-7718
Pavlo VirychFaculty of Chemistry of Taras Shevchenko National University of Kyiv 12, Hetmana Pavla Skoropadskoho Street. Kyiv 01033 Ukraine.ORCID https://orcid.org/0000-0002-1463-1992
Joaquin Silvestre-AlberoLaboratorio de Materiales Avanzados, Instituto Universitario de Materiales-Departamento de Química Inorgánica, University of Alicante Ctra. San Vicente-Alicante s/n E-03080 Alicante Spain.ORCID https://orcid.org/0000-0002-0303-0817
Anatolii BelousV. I. Vernadsky Institute of General and Inorganic Chemistry of the NAS of Ukraine 32/34 Palladina Ave Kyiv 03142 Ukraine yuliashlapa@ukr.net.ORCID https://orcid.org/0000-0001-7808-3828

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of advanced nanomaterials capable of modulating cellular redox homeostasis is critical for photoprotection and regenerative medicine. This study presents a comprehensive evaluation of a hybrid "carbon-cerium dioxide nanocomposite" (C@CeO

Identifiers

PMID42639220
PMCPMC13502252

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.